Biomed Research International-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2095355, encodeId=b6e4209535554, content=8.19 提交 9.7 AE invited 9.8 submitted 9.23 AE invited 9.27 Reviewers invited 10.12 under review 10.13 pending approval 10.16 小修 10.22 修回 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=968b8161946, createdName=ms7000001999513863, createdTime=Sat Oct 22 11:56:35 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093439, encodeId=958b209343994, content=这个杂志从接收到proof要多久啊好多天了都没有校稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/f15aef288ba84b4a8a66f16a69e107c9/02963d8dfe4d42e49ccdbaddde9bccec.jpg, createdBy=58185576212, createdName=liuhuumin, createdTime=Wed Oct 12 18:01:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093153, encodeId=d444209315389, content=这个杂志，一般投特刊还是普刊，审稿时间一般多长呀谢谢各位了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 16:50:05 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091546, encodeId=fc5520915468f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;病毒学 经验分享：从8月到10月，审了三篇稿件，都是同一个编辑发的审稿邀请，涉及oncology， cell biology 等领域，2篇是医科大附属医院的，1篇为地方普通二本，都是中国人的稿件。给了2个reject，1个minor revision。给reject的2篇连一些实验检测手段都搞不懂，实验设计和结果有硬伤！到我手里的稿子基本都是已投稿2个月或3个月以上的，可能是没人审稿或者是审稿意见相反又找的审稿人。整体感觉稿件质量较差！这也是官网显示接收率较低的重要原因！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8f02112635, createdName=疯疯王, createdTime=Mon Oct 03 02:26:06 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090310, encodeId=f98d20903103b, content=真是的…好焦虑啊，大修之后又让我小修，现在距离小修返稿已经一周了，还是under review这是怎么回事啊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sun Sep 25 17:35:26 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090203, encodeId=76a42090203d1, content=这个杂志一般给审稿人多长时间审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sat Sep 24 22:22:19 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248378, encodeId=2dd812483e865, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2月21号投稿，8月20号接收，9月10日要求Proof，我想请问最近投稿成功的小伙伴需不需要每个作者都有ORCID, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKO5TmNicXMnIt3G19a3icu90nhvoat83z1sDoQc1x7NQs3Y9ekdoYbpj8iaGS8wPibQzgcC6LeGaguoQ/132, createdBy=ff4f2554003, createdName=150254a6dfm, createdTime=Sun Sep 11 14:18:56 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248491, encodeId=f06512484916f, content=诸位大佬，请问一下数据可用性声明怎么写，官网上给的链接找不到上传的按钮, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf18319688, createdName=ms9000002066913354, createdTime=Mon Sep 12 11:59:56 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242568, encodeId=4692124256882, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：under review就用了3天被拒的概率大吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Thu Sep 01 22:09:33 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240690, encodeId=71ab124069027, content=请问这个杂志是需要所有作者都确认投稿之后，才算是完成投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec7d8255535, createdName=ms4000001660610604, createdTime=Wed Aug 24 11:54:27 CST 2022, time=2022-08-24, status=1, ipAttribution=)]

2022-10-22 ms7000001999513863

8.19 提交
9.7 AE invited
9.8 submitted
9.23 AE invited
9.27 Reviewers invited
10.12 under review
10.13 pending approval
10.16 小修
10.22 修回 under review

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2095355, encodeId=b6e4209535554, content=8.19 提交 9.7 AE invited 9.8 submitted 9.23 AE invited 9.27 Reviewers invited 10.12 under review 10.13 pending approval 10.16 小修 10.22 修回 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=968b8161946, createdName=ms7000001999513863, createdTime=Sat Oct 22 11:56:35 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093439, encodeId=958b209343994, content=这个杂志从接收到proof要多久啊好多天了都没有校稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/f15aef288ba84b4a8a66f16a69e107c9/02963d8dfe4d42e49ccdbaddde9bccec.jpg, createdBy=58185576212, createdName=liuhuumin, createdTime=Wed Oct 12 18:01:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093153, encodeId=d444209315389, content=这个杂志，一般投特刊还是普刊，审稿时间一般多长呀谢谢各位了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 16:50:05 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091546, encodeId=fc5520915468f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;病毒学 经验分享：从8月到10月，审了三篇稿件，都是同一个编辑发的审稿邀请，涉及oncology， cell biology 等领域，2篇是医科大附属医院的，1篇为地方普通二本，都是中国人的稿件。给了2个reject，1个minor revision。给reject的2篇连一些实验检测手段都搞不懂，实验设计和结果有硬伤！到我手里的稿子基本都是已投稿2个月或3个月以上的，可能是没人审稿或者是审稿意见相反又找的审稿人。整体感觉稿件质量较差！这也是官网显示接收率较低的重要原因！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8f02112635, createdName=疯疯王, createdTime=Mon Oct 03 02:26:06 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090310, encodeId=f98d20903103b, content=真是的…好焦虑啊，大修之后又让我小修，现在距离小修返稿已经一周了，还是under review这是怎么回事啊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sun Sep 25 17:35:26 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090203, encodeId=76a42090203d1, content=这个杂志一般给审稿人多长时间审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sat Sep 24 22:22:19 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248378, encodeId=2dd812483e865, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2月21号投稿，8月20号接收，9月10日要求Proof，我想请问最近投稿成功的小伙伴需不需要每个作者都有ORCID, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKO5TmNicXMnIt3G19a3icu90nhvoat83z1sDoQc1x7NQs3Y9ekdoYbpj8iaGS8wPibQzgcC6LeGaguoQ/132, createdBy=ff4f2554003, createdName=150254a6dfm, createdTime=Sun Sep 11 14:18:56 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248491, encodeId=f06512484916f, content=诸位大佬，请问一下数据可用性声明怎么写，官网上给的链接找不到上传的按钮, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf18319688, createdName=ms9000002066913354, createdTime=Mon Sep 12 11:59:56 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242568, encodeId=4692124256882, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：under review就用了3天被拒的概率大吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Thu Sep 01 22:09:33 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240690, encodeId=71ab124069027, content=请问这个杂志是需要所有作者都确认投稿之后，才算是完成投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec7d8255535, createdName=ms4000001660610604, createdTime=Wed Aug 24 11:54:27 CST 2022, time=2022-08-24, status=1, ipAttribution=)]

2022-10-12 liuhuumin

这个杂志从接收到proof要多久啊好多天了都没有校稿

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2095355, encodeId=b6e4209535554, content=8.19 提交 9.7 AE invited 9.8 submitted 9.23 AE invited 9.27 Reviewers invited 10.12 under review 10.13 pending approval 10.16 小修 10.22 修回 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=968b8161946, createdName=ms7000001999513863, createdTime=Sat Oct 22 11:56:35 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093439, encodeId=958b209343994, content=这个杂志从接收到proof要多久啊好多天了都没有校稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/f15aef288ba84b4a8a66f16a69e107c9/02963d8dfe4d42e49ccdbaddde9bccec.jpg, createdBy=58185576212, createdName=liuhuumin, createdTime=Wed Oct 12 18:01:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093153, encodeId=d444209315389, content=这个杂志，一般投特刊还是普刊，审稿时间一般多长呀谢谢各位了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 16:50:05 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091546, encodeId=fc5520915468f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;病毒学 经验分享：从8月到10月，审了三篇稿件，都是同一个编辑发的审稿邀请，涉及oncology， cell biology 等领域，2篇是医科大附属医院的，1篇为地方普通二本，都是中国人的稿件。给了2个reject，1个minor revision。给reject的2篇连一些实验检测手段都搞不懂，实验设计和结果有硬伤！到我手里的稿子基本都是已投稿2个月或3个月以上的，可能是没人审稿或者是审稿意见相反又找的审稿人。整体感觉稿件质量较差！这也是官网显示接收率较低的重要原因！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8f02112635, createdName=疯疯王, createdTime=Mon Oct 03 02:26:06 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090310, encodeId=f98d20903103b, content=真是的…好焦虑啊，大修之后又让我小修，现在距离小修返稿已经一周了，还是under review这是怎么回事啊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sun Sep 25 17:35:26 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090203, encodeId=76a42090203d1, content=这个杂志一般给审稿人多长时间审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sat Sep 24 22:22:19 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248378, encodeId=2dd812483e865, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2月21号投稿，8月20号接收，9月10日要求Proof，我想请问最近投稿成功的小伙伴需不需要每个作者都有ORCID, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKO5TmNicXMnIt3G19a3icu90nhvoat83z1sDoQc1x7NQs3Y9ekdoYbpj8iaGS8wPibQzgcC6LeGaguoQ/132, createdBy=ff4f2554003, createdName=150254a6dfm, createdTime=Sun Sep 11 14:18:56 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248491, encodeId=f06512484916f, content=诸位大佬，请问一下数据可用性声明怎么写，官网上给的链接找不到上传的按钮, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf18319688, createdName=ms9000002066913354, createdTime=Mon Sep 12 11:59:56 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242568, encodeId=4692124256882, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：under review就用了3天被拒的概率大吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Thu Sep 01 22:09:33 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240690, encodeId=71ab124069027, content=请问这个杂志是需要所有作者都确认投稿之后，才算是完成投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec7d8255535, createdName=ms4000001660610604, createdTime=Wed Aug 24 11:54:27 CST 2022, time=2022-08-24, status=1, ipAttribution=)]

2022-10-11 ms8000000524560535

这个杂志，一般投特刊还是普刊，审稿时间一般多长呀谢谢各位了

18 0

[GetPortalCommentsPageByObjectIdResponse(id=2095355, encodeId=b6e4209535554, content=8.19 提交 9.7 AE invited 9.8 submitted 9.23 AE invited 9.27 Reviewers invited 10.12 under review 10.13 pending approval 10.16 小修 10.22 修回 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=968b8161946, createdName=ms7000001999513863, createdTime=Sat Oct 22 11:56:35 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093439, encodeId=958b209343994, content=这个杂志从接收到proof要多久啊好多天了都没有校稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/f15aef288ba84b4a8a66f16a69e107c9/02963d8dfe4d42e49ccdbaddde9bccec.jpg, createdBy=58185576212, createdName=liuhuumin, createdTime=Wed Oct 12 18:01:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093153, encodeId=d444209315389, content=这个杂志，一般投特刊还是普刊，审稿时间一般多长呀谢谢各位了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 16:50:05 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091546, encodeId=fc5520915468f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;病毒学 经验分享：从8月到10月，审了三篇稿件，都是同一个编辑发的审稿邀请，涉及oncology， cell biology 等领域，2篇是医科大附属医院的，1篇为地方普通二本，都是中国人的稿件。给了2个reject，1个minor revision。给reject的2篇连一些实验检测手段都搞不懂，实验设计和结果有硬伤！到我手里的稿子基本都是已投稿2个月或3个月以上的，可能是没人审稿或者是审稿意见相反又找的审稿人。整体感觉稿件质量较差！这也是官网显示接收率较低的重要原因！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8f02112635, createdName=疯疯王, createdTime=Mon Oct 03 02:26:06 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090310, encodeId=f98d20903103b, content=真是的…好焦虑啊，大修之后又让我小修，现在距离小修返稿已经一周了，还是under review这是怎么回事啊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sun Sep 25 17:35:26 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090203, encodeId=76a42090203d1, content=这个杂志一般给审稿人多长时间审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sat Sep 24 22:22:19 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248378, encodeId=2dd812483e865, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2月21号投稿，8月20号接收，9月10日要求Proof，我想请问最近投稿成功的小伙伴需不需要每个作者都有ORCID, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKO5TmNicXMnIt3G19a3icu90nhvoat83z1sDoQc1x7NQs3Y9ekdoYbpj8iaGS8wPibQzgcC6LeGaguoQ/132, createdBy=ff4f2554003, createdName=150254a6dfm, createdTime=Sun Sep 11 14:18:56 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248491, encodeId=f06512484916f, content=诸位大佬，请问一下数据可用性声明怎么写，官网上给的链接找不到上传的按钮, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf18319688, createdName=ms9000002066913354, createdTime=Mon Sep 12 11:59:56 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242568, encodeId=4692124256882, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：under review就用了3天被拒的概率大吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Thu Sep 01 22:09:33 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240690, encodeId=71ab124069027, content=请问这个杂志是需要所有作者都确认投稿之后，才算是完成投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec7d8255535, createdName=ms4000001660610604, createdTime=Wed Aug 24 11:54:27 CST 2022, time=2022-08-24, status=1, ipAttribution=)]

2022-10-03 疯疯王

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：分子生物学;病毒学
经验分享：从8月到10月，审了三篇稿件，都是同一个编辑发的审稿邀请，涉及oncology， cell biology 等领域，2篇是医科大附属医院的，1篇为地方普通二本，都是中国人的稿件。给了2个reject，1个minor revision。给reject的2篇连一些实验检测手段都搞不懂，实验设计和结果有硬伤！到我手里的稿子基本都是已投稿2个月或3个月以上的，可能是没人审稿或者是审稿意见相反又找的审稿人。整体感觉稿件质量较差！这也是官网显示接收率较低的重要原因！

55 0

[GetPortalCommentsPageByObjectIdResponse(id=2095355, encodeId=b6e4209535554, content=8.19 提交 9.7 AE invited 9.8 submitted 9.23 AE invited 9.27 Reviewers invited 10.12 under review 10.13 pending approval 10.16 小修 10.22 修回 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=968b8161946, createdName=ms7000001999513863, createdTime=Sat Oct 22 11:56:35 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093439, encodeId=958b209343994, content=这个杂志从接收到proof要多久啊好多天了都没有校稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/f15aef288ba84b4a8a66f16a69e107c9/02963d8dfe4d42e49ccdbaddde9bccec.jpg, createdBy=58185576212, createdName=liuhuumin, createdTime=Wed Oct 12 18:01:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093153, encodeId=d444209315389, content=这个杂志，一般投特刊还是普刊，审稿时间一般多长呀谢谢各位了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 16:50:05 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091546, encodeId=fc5520915468f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;病毒学 经验分享：从8月到10月，审了三篇稿件，都是同一个编辑发的审稿邀请，涉及oncology， cell biology 等领域，2篇是医科大附属医院的，1篇为地方普通二本，都是中国人的稿件。给了2个reject，1个minor revision。给reject的2篇连一些实验检测手段都搞不懂，实验设计和结果有硬伤！到我手里的稿子基本都是已投稿2个月或3个月以上的，可能是没人审稿或者是审稿意见相反又找的审稿人。整体感觉稿件质量较差！这也是官网显示接收率较低的重要原因！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8f02112635, createdName=疯疯王, createdTime=Mon Oct 03 02:26:06 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090310, encodeId=f98d20903103b, content=真是的…好焦虑啊，大修之后又让我小修，现在距离小修返稿已经一周了，还是under review这是怎么回事啊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sun Sep 25 17:35:26 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090203, encodeId=76a42090203d1, content=这个杂志一般给审稿人多长时间审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sat Sep 24 22:22:19 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248378, encodeId=2dd812483e865, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2月21号投稿，8月20号接收，9月10日要求Proof，我想请问最近投稿成功的小伙伴需不需要每个作者都有ORCID, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKO5TmNicXMnIt3G19a3icu90nhvoat83z1sDoQc1x7NQs3Y9ekdoYbpj8iaGS8wPibQzgcC6LeGaguoQ/132, createdBy=ff4f2554003, createdName=150254a6dfm, createdTime=Sun Sep 11 14:18:56 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248491, encodeId=f06512484916f, content=诸位大佬，请问一下数据可用性声明怎么写，官网上给的链接找不到上传的按钮, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf18319688, createdName=ms9000002066913354, createdTime=Mon Sep 12 11:59:56 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242568, encodeId=4692124256882, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：under review就用了3天被拒的概率大吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Thu Sep 01 22:09:33 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240690, encodeId=71ab124069027, content=请问这个杂志是需要所有作者都确认投稿之后，才算是完成投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec7d8255535, createdName=ms4000001660610604, createdTime=Wed Aug 24 11:54:27 CST 2022, time=2022-08-24, status=1, ipAttribution=)]

2022-09-25 ms1000000814905428

真是的…好焦虑啊，大修之后又让我小修，现在距离小修返稿已经一周了，还是under review这是怎么回事啊。

25 0

[GetPortalCommentsPageByObjectIdResponse(id=2095355, encodeId=b6e4209535554, content=8.19 提交 9.7 AE invited 9.8 submitted 9.23 AE invited 9.27 Reviewers invited 10.12 under review 10.13 pending approval 10.16 小修 10.22 修回 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=968b8161946, createdName=ms7000001999513863, createdTime=Sat Oct 22 11:56:35 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093439, encodeId=958b209343994, content=这个杂志从接收到proof要多久啊好多天了都没有校稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/f15aef288ba84b4a8a66f16a69e107c9/02963d8dfe4d42e49ccdbaddde9bccec.jpg, createdBy=58185576212, createdName=liuhuumin, createdTime=Wed Oct 12 18:01:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093153, encodeId=d444209315389, content=这个杂志，一般投特刊还是普刊，审稿时间一般多长呀谢谢各位了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 16:50:05 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091546, encodeId=fc5520915468f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;病毒学 经验分享：从8月到10月，审了三篇稿件，都是同一个编辑发的审稿邀请，涉及oncology， cell biology 等领域，2篇是医科大附属医院的，1篇为地方普通二本，都是中国人的稿件。给了2个reject，1个minor revision。给reject的2篇连一些实验检测手段都搞不懂，实验设计和结果有硬伤！到我手里的稿子基本都是已投稿2个月或3个月以上的，可能是没人审稿或者是审稿意见相反又找的审稿人。整体感觉稿件质量较差！这也是官网显示接收率较低的重要原因！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8f02112635, createdName=疯疯王, createdTime=Mon Oct 03 02:26:06 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090310, encodeId=f98d20903103b, content=真是的…好焦虑啊，大修之后又让我小修，现在距离小修返稿已经一周了，还是under review这是怎么回事啊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sun Sep 25 17:35:26 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090203, encodeId=76a42090203d1, content=这个杂志一般给审稿人多长时间审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sat Sep 24 22:22:19 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248378, encodeId=2dd812483e865, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2月21号投稿，8月20号接收，9月10日要求Proof，我想请问最近投稿成功的小伙伴需不需要每个作者都有ORCID, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKO5TmNicXMnIt3G19a3icu90nhvoat83z1sDoQc1x7NQs3Y9ekdoYbpj8iaGS8wPibQzgcC6LeGaguoQ/132, createdBy=ff4f2554003, createdName=150254a6dfm, createdTime=Sun Sep 11 14:18:56 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248491, encodeId=f06512484916f, content=诸位大佬，请问一下数据可用性声明怎么写，官网上给的链接找不到上传的按钮, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf18319688, createdName=ms9000002066913354, createdTime=Mon Sep 12 11:59:56 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242568, encodeId=4692124256882, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：under review就用了3天被拒的概率大吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Thu Sep 01 22:09:33 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240690, encodeId=71ab124069027, content=请问这个杂志是需要所有作者都确认投稿之后，才算是完成投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec7d8255535, createdName=ms4000001660610604, createdTime=Wed Aug 24 11:54:27 CST 2022, time=2022-08-24, status=1, ipAttribution=)]

2022-09-24 ms1000000814905428

这个杂志一般给审稿人多长时间审稿

47 0

[GetPortalCommentsPageByObjectIdResponse(id=2095355, encodeId=b6e4209535554, content=8.19 提交 9.7 AE invited 9.8 submitted 9.23 AE invited 9.27 Reviewers invited 10.12 under review 10.13 pending approval 10.16 小修 10.22 修回 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=968b8161946, createdName=ms7000001999513863, createdTime=Sat Oct 22 11:56:35 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093439, encodeId=958b209343994, content=这个杂志从接收到proof要多久啊好多天了都没有校稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/f15aef288ba84b4a8a66f16a69e107c9/02963d8dfe4d42e49ccdbaddde9bccec.jpg, createdBy=58185576212, createdName=liuhuumin, createdTime=Wed Oct 12 18:01:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093153, encodeId=d444209315389, content=这个杂志，一般投特刊还是普刊，审稿时间一般多长呀谢谢各位了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 16:50:05 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091546, encodeId=fc5520915468f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;病毒学 经验分享：从8月到10月，审了三篇稿件，都是同一个编辑发的审稿邀请，涉及oncology， cell biology 等领域，2篇是医科大附属医院的，1篇为地方普通二本，都是中国人的稿件。给了2个reject，1个minor revision。给reject的2篇连一些实验检测手段都搞不懂，实验设计和结果有硬伤！到我手里的稿子基本都是已投稿2个月或3个月以上的，可能是没人审稿或者是审稿意见相反又找的审稿人。整体感觉稿件质量较差！这也是官网显示接收率较低的重要原因！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8f02112635, createdName=疯疯王, createdTime=Mon Oct 03 02:26:06 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090310, encodeId=f98d20903103b, content=真是的…好焦虑啊，大修之后又让我小修，现在距离小修返稿已经一周了，还是under review这是怎么回事啊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sun Sep 25 17:35:26 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090203, encodeId=76a42090203d1, content=这个杂志一般给审稿人多长时间审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sat Sep 24 22:22:19 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248378, encodeId=2dd812483e865, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2月21号投稿，8月20号接收，9月10日要求Proof，我想请问最近投稿成功的小伙伴需不需要每个作者都有ORCID, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKO5TmNicXMnIt3G19a3icu90nhvoat83z1sDoQc1x7NQs3Y9ekdoYbpj8iaGS8wPibQzgcC6LeGaguoQ/132, createdBy=ff4f2554003, createdName=150254a6dfm, createdTime=Sun Sep 11 14:18:56 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248491, encodeId=f06512484916f, content=诸位大佬，请问一下数据可用性声明怎么写，官网上给的链接找不到上传的按钮, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf18319688, createdName=ms9000002066913354, createdTime=Mon Sep 12 11:59:56 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242568, encodeId=4692124256882, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：under review就用了3天被拒的概率大吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Thu Sep 01 22:09:33 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240690, encodeId=71ab124069027, content=请问这个杂志是需要所有作者都确认投稿之后，才算是完成投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec7d8255535, createdName=ms4000001660610604, createdTime=Wed Aug 24 11:54:27 CST 2022, time=2022-08-24, status=1, ipAttribution=)]

2022-09-11 150254a6dfm

审稿速度:6.0 | 投稿命中率:50.0
经验分享：2月21号投稿，8月20号接收，9月10日要求Proof，我想请问最近投稿成功的小伙伴需不需要每个作者都有ORCID

31 0

[GetPortalCommentsPageByObjectIdResponse(id=2095355, encodeId=b6e4209535554, content=8.19 提交 9.7 AE invited 9.8 submitted 9.23 AE invited 9.27 Reviewers invited 10.12 under review 10.13 pending approval 10.16 小修 10.22 修回 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=968b8161946, createdName=ms7000001999513863, createdTime=Sat Oct 22 11:56:35 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093439, encodeId=958b209343994, content=这个杂志从接收到proof要多久啊好多天了都没有校稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/f15aef288ba84b4a8a66f16a69e107c9/02963d8dfe4d42e49ccdbaddde9bccec.jpg, createdBy=58185576212, createdName=liuhuumin, createdTime=Wed Oct 12 18:01:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093153, encodeId=d444209315389, content=这个杂志，一般投特刊还是普刊，审稿时间一般多长呀谢谢各位了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 16:50:05 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091546, encodeId=fc5520915468f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;病毒学 经验分享：从8月到10月，审了三篇稿件，都是同一个编辑发的审稿邀请，涉及oncology， cell biology 等领域，2篇是医科大附属医院的，1篇为地方普通二本，都是中国人的稿件。给了2个reject，1个minor revision。给reject的2篇连一些实验检测手段都搞不懂，实验设计和结果有硬伤！到我手里的稿子基本都是已投稿2个月或3个月以上的，可能是没人审稿或者是审稿意见相反又找的审稿人。整体感觉稿件质量较差！这也是官网显示接收率较低的重要原因！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8f02112635, createdName=疯疯王, createdTime=Mon Oct 03 02:26:06 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090310, encodeId=f98d20903103b, content=真是的…好焦虑啊，大修之后又让我小修，现在距离小修返稿已经一周了，还是under review这是怎么回事啊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sun Sep 25 17:35:26 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090203, encodeId=76a42090203d1, content=这个杂志一般给审稿人多长时间审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sat Sep 24 22:22:19 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248378, encodeId=2dd812483e865, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2月21号投稿，8月20号接收，9月10日要求Proof，我想请问最近投稿成功的小伙伴需不需要每个作者都有ORCID, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKO5TmNicXMnIt3G19a3icu90nhvoat83z1sDoQc1x7NQs3Y9ekdoYbpj8iaGS8wPibQzgcC6LeGaguoQ/132, createdBy=ff4f2554003, createdName=150254a6dfm, createdTime=Sun Sep 11 14:18:56 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248491, encodeId=f06512484916f, content=诸位大佬，请问一下数据可用性声明怎么写，官网上给的链接找不到上传的按钮, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf18319688, createdName=ms9000002066913354, createdTime=Mon Sep 12 11:59:56 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242568, encodeId=4692124256882, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：under review就用了3天被拒的概率大吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Thu Sep 01 22:09:33 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240690, encodeId=71ab124069027, content=请问这个杂志是需要所有作者都确认投稿之后，才算是完成投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec7d8255535, createdName=ms4000001660610604, createdTime=Wed Aug 24 11:54:27 CST 2022, time=2022-08-24, status=1, ipAttribution=)]

2022-09-12 ms9000002066913354

诸位大佬，请问一下数据可用性声明怎么写，官网上给的链接找不到上传的按钮

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2095355, encodeId=b6e4209535554, content=8.19 提交 9.7 AE invited 9.8 submitted 9.23 AE invited 9.27 Reviewers invited 10.12 under review 10.13 pending approval 10.16 小修 10.22 修回 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=968b8161946, createdName=ms7000001999513863, createdTime=Sat Oct 22 11:56:35 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093439, encodeId=958b209343994, content=这个杂志从接收到proof要多久啊好多天了都没有校稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/f15aef288ba84b4a8a66f16a69e107c9/02963d8dfe4d42e49ccdbaddde9bccec.jpg, createdBy=58185576212, createdName=liuhuumin, createdTime=Wed Oct 12 18:01:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093153, encodeId=d444209315389, content=这个杂志，一般投特刊还是普刊，审稿时间一般多长呀谢谢各位了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 16:50:05 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091546, encodeId=fc5520915468f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;病毒学 经验分享：从8月到10月，审了三篇稿件，都是同一个编辑发的审稿邀请，涉及oncology， cell biology 等领域，2篇是医科大附属医院的，1篇为地方普通二本，都是中国人的稿件。给了2个reject，1个minor revision。给reject的2篇连一些实验检测手段都搞不懂，实验设计和结果有硬伤！到我手里的稿子基本都是已投稿2个月或3个月以上的，可能是没人审稿或者是审稿意见相反又找的审稿人。整体感觉稿件质量较差！这也是官网显示接收率较低的重要原因！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8f02112635, createdName=疯疯王, createdTime=Mon Oct 03 02:26:06 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090310, encodeId=f98d20903103b, content=真是的…好焦虑啊，大修之后又让我小修，现在距离小修返稿已经一周了，还是under review这是怎么回事啊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sun Sep 25 17:35:26 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090203, encodeId=76a42090203d1, content=这个杂志一般给审稿人多长时间审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sat Sep 24 22:22:19 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248378, encodeId=2dd812483e865, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2月21号投稿，8月20号接收，9月10日要求Proof，我想请问最近投稿成功的小伙伴需不需要每个作者都有ORCID, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKO5TmNicXMnIt3G19a3icu90nhvoat83z1sDoQc1x7NQs3Y9ekdoYbpj8iaGS8wPibQzgcC6LeGaguoQ/132, createdBy=ff4f2554003, createdName=150254a6dfm, createdTime=Sun Sep 11 14:18:56 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248491, encodeId=f06512484916f, content=诸位大佬，请问一下数据可用性声明怎么写，官网上给的链接找不到上传的按钮, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf18319688, createdName=ms9000002066913354, createdTime=Mon Sep 12 11:59:56 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242568, encodeId=4692124256882, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：under review就用了3天被拒的概率大吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Thu Sep 01 22:09:33 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240690, encodeId=71ab124069027, content=请问这个杂志是需要所有作者都确认投稿之后，才算是完成投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec7d8255535, createdName=ms4000001660610604, createdTime=Wed Aug 24 11:54:27 CST 2022, time=2022-08-24, status=1, ipAttribution=)]

2022-09-01 ms1000000814905428

审稿速度:1.0 | 投稿命中率:50.0
经验分享：under review就用了3天被拒的概率大吗。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2095355, encodeId=b6e4209535554, content=8.19 提交 9.7 AE invited 9.8 submitted 9.23 AE invited 9.27 Reviewers invited 10.12 under review 10.13 pending approval 10.16 小修 10.22 修回 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=968b8161946, createdName=ms7000001999513863, createdTime=Sat Oct 22 11:56:35 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093439, encodeId=958b209343994, content=这个杂志从接收到proof要多久啊好多天了都没有校稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/f15aef288ba84b4a8a66f16a69e107c9/02963d8dfe4d42e49ccdbaddde9bccec.jpg, createdBy=58185576212, createdName=liuhuumin, createdTime=Wed Oct 12 18:01:59 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093153, encodeId=d444209315389, content=这个杂志，一般投特刊还是普刊，审稿时间一般多长呀谢谢各位了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 16:50:05 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091546, encodeId=fc5520915468f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;病毒学 经验分享：从8月到10月，审了三篇稿件，都是同一个编辑发的审稿邀请，涉及oncology， cell biology 等领域，2篇是医科大附属医院的，1篇为地方普通二本，都是中国人的稿件。给了2个reject，1个minor revision。给reject的2篇连一些实验检测手段都搞不懂，实验设计和结果有硬伤！到我手里的稿子基本都是已投稿2个月或3个月以上的，可能是没人审稿或者是审稿意见相反又找的审稿人。整体感觉稿件质量较差！这也是官网显示接收率较低的重要原因！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8f02112635, createdName=疯疯王, createdTime=Mon Oct 03 02:26:06 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090310, encodeId=f98d20903103b, content=真是的…好焦虑啊，大修之后又让我小修，现在距离小修返稿已经一周了，还是under review这是怎么回事啊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sun Sep 25 17:35:26 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090203, encodeId=76a42090203d1, content=这个杂志一般给审稿人多长时间审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Sat Sep 24 22:22:19 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248378, encodeId=2dd812483e865, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2月21号投稿，8月20号接收，9月10日要求Proof，我想请问最近投稿成功的小伙伴需不需要每个作者都有ORCID, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKO5TmNicXMnIt3G19a3icu90nhvoat83z1sDoQc1x7NQs3Y9ekdoYbpj8iaGS8wPibQzgcC6LeGaguoQ/132, createdBy=ff4f2554003, createdName=150254a6dfm, createdTime=Sun Sep 11 14:18:56 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248491, encodeId=f06512484916f, content=诸位大佬，请问一下数据可用性声明怎么写，官网上给的链接找不到上传的按钮, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cf18319688, createdName=ms9000002066913354, createdTime=Mon Sep 12 11:59:56 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242568, encodeId=4692124256882, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：under review就用了3天被拒的概率大吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18066560281, createdName=ms1000000814905428, createdTime=Thu Sep 01 22:09:33 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240690, encodeId=71ab124069027, content=请问这个杂志是需要所有作者都确认投稿之后，才算是完成投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec7d8255535, createdName=ms4000001660610604, createdTime=Wed Aug 24 11:54:27 CST 2022, time=2022-08-24, status=1, ipAttribution=)]

2022-08-24 ms4000001660610604

请问这个杂志是需要所有作者都确认投稿之后，才算是完成投稿吗？

34 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务